Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/18/1997 | CA2258127A1 Genes enhancing disease resistance in plants |
12/18/1997 | CA2258016A1 Compositions and methods for administering borrelia dna |
12/18/1997 | CA2258007A1 Methods and compositions for transforming cells |
12/18/1997 | CA2257991A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
12/18/1997 | CA2257916A1 Generating replicating molecules in vivo |
12/18/1997 | CA2257829A1 Chitinase materials and methods |
12/18/1997 | CA2257373A1 Il-1/tnf-.alpha.-activated kinase (itak), and methods of making and using the same |
12/18/1997 | CA2256459A1 T-cell selective interleukin-4 agonists |
12/18/1997 | CA2251575A1 Compounds that interfere with dna replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds |
12/17/1997 | EP0812916A2 Cathepsin k gene |
12/17/1997 | EP0812912A1 RNA Catalyst for cleaving specific RNA sequences |
12/17/1997 | EP0812859A1 ANTIFACTOR Xa-TISSUE FACTOR PATHWAY INHIBITOR COMPLEX MONOCLONAL ANTIBODY AND USE OF THE SAME |
12/17/1997 | EP0812594A1 Compounds that interfere with DNA replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds |
12/17/1997 | EP0812357A1 A method for making heteromultimeric polypeptides |
12/17/1997 | EP0812356A1 Prostate-specific membrane antigen and uses thereof |
12/17/1997 | EP0812353A2 Prostaglandin receptor dp |
12/17/1997 | EP0812352A1 Redirection of cellular immunity by protein-tyrosine kinase chimeras |
12/17/1997 | EP0812351A1 Three-dimensional cartilage cultures |
12/17/1997 | EP0812333A1 Bispecific antibody effective to treat b-cell lymphoma and cell line |
12/17/1997 | EP0812329A1 Human g-protein coupled receptor |
12/17/1997 | EP0812210A1 Compositions and methods for enhancing the growth of hair and restoring hair color |
12/17/1997 | EP0812201A1 $i(IN VITRO) AMPLIFICATION OF STEM CELLS |
12/17/1997 | EP0716570A4 Genetically modified human hematopoietic stem cells and their progeny |
12/17/1997 | EP0693132B1 Rapamycin assay |
12/17/1997 | EP0616528B1 Implantable capsule |
12/17/1997 | EP0607332B1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
12/17/1997 | EP0557535B1 HUMAN MONOCLONAL ANTIBODY AGAINST GLYCOPROTEIN IIb/IIIa |
12/17/1997 | EP0540599B1 Adoptive immunotherapy with interleukin-7 |
12/17/1997 | EP0494293B1 Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection |
12/16/1997 | US5698530 A vaccinia virus into which carcinoembryonic antigen gene is inserteted; induce an active immune response |
12/16/1997 | US5698520 Peptide related to human programmed cell death and DNA encoding the same |
12/16/1997 | US5698517 Thyroxin-binding HSA fragments |
12/16/1997 | US5698446 Methods and compositions for inhibiting production of replication competent virus |
12/16/1997 | US5698445 Human PAK65 |
12/16/1997 | US5698436 Introduction and expression of foreign genetic material in epithelial cells |
12/16/1997 | US5698428 Human PAK65 |
12/16/1997 | US5698425 Method of protecting plants by transformation with genes for the synthesis of antipathogenic substances |
12/16/1997 | US5698419 Formed by fusion of cells from mouse myeloma line and spleen cells from mouse previously immunized with cachectin-tumor necrosis factor |
12/16/1997 | US5698403 Methods of detecting platelet-activating factor acetylhydrolase using antibodies |
12/16/1997 | US5698390 Incubating sample including hepatitis c polypeptide that binds to antibody under conditions that allow for formation of antibody-antigen complex |
12/16/1997 | US5698203 Attenuated viruse reactive with monoclonal antibody a27 |
12/16/1997 | US5698198 Method for treating gram negative bacterial infections in humans |
12/16/1997 | US5698196 Antibodies specific for neutrophic chemotactic factor |
12/16/1997 | US5698194 Method for making a medicament for treating secondary immunodeficiency |
12/16/1997 | CA1339583C Monoclonal antibody nuh2 capable of inactivating motility of human sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen |
12/16/1997 | CA1339582C Monoclonal antibodies and methods for diagnosis of phytophthora infection |
12/14/1997 | CA2179101A1 Preparation and storage of pancreatic islets |
12/11/1997 | WO1997046885A1 DIAGNOSTIC METHOD FOR DETECTION OF MOLECULAR FORMS OF EOSINOPHILIC CATIONIC PROTEIN (iso-ECPs) |
12/11/1997 | WO1997046710A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof |
12/11/1997 | WO1997046697A3 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
12/11/1997 | WO1997046697A2 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
12/11/1997 | WO1997046692A1 Nematode-inducible plant gene promoter |
12/11/1997 | WO1997046690A1 Enhancement of gene expression |
12/11/1997 | WO1997046688A1 Lipid kinase |
12/11/1997 | WO1997046687A1 Vectors comprising sar elements |
12/11/1997 | WO1997046685A1 Polynucleotides encoding secreted proteins from human dendritic cells |
12/11/1997 | WO1997046683A2 Polynucleotides encoding secreted proteins |
12/11/1997 | WO1997046682A2 Polynucleotides from human adult pbmc encoding secreted proteins |
12/11/1997 | WO1997046681A2 GALANIN RECEPTOR GalR2 |
12/11/1997 | WO1997046680A1 Dna encoding dp. 75 and a process for its use |
12/11/1997 | WO1997046676A1 Tumor antigen proteins, genes thereof, and tumor antigen peptides |
12/11/1997 | WO1997046675A1 Metabotropic gaba[b] receptors, receptor-specific ligands and their uses |
12/11/1997 | WO1997046673A2 Inhibition of hiv-1 replication by antisense rna expression |
12/11/1997 | WO1997046672A2 Antisense nucleic acids and hammerhead ribozymes |
12/11/1997 | WO1997046665A1 Method for making cartilage and implants |
12/11/1997 | WO1997046664A1 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses |
12/11/1997 | WO1997046590A1 Materials and methods for the immobilization of bioactive species onto polymeric substrates |
12/11/1997 | WO1997046589A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
12/11/1997 | WO1997046581A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
12/11/1997 | WO1997046572A1 Transgenic animals expressing artificial epitope-tagged proteins |
12/11/1997 | WO1997046259A2 Chimeric toxin for targeted therapy |
12/11/1997 | WO1997046256A1 Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells |
12/11/1997 | WO1997046206A2 Human thyrotropin receptor compositions and use thereof |
12/11/1997 | WO1997046100A1 Serpin enzyme complex receptor-mediated gene transfer |
12/11/1997 | WO1997041443A3 Method for screening compounds |
12/11/1997 | WO1997039107A3 Methods for increasing the maturation of cells |
12/11/1997 | CA2258720A1 Human thyrotropin receptor compositions and use thereof |
12/11/1997 | CA2257943A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
12/11/1997 | CA2257531A1 Tumor antigen proteins, genes thereof, and tumor antigen peptides |
12/11/1997 | CA2257243A1 Polynucleotides from human adult pbmc encoding secreted proteins |
12/11/1997 | CA2257149A1 Nematode-inducible plant gene promoter |
12/11/1997 | CA2257117A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof |
12/11/1997 | CA2256558A1 Serpin enzyme complex receptor-mediated gene transfer |
12/11/1997 | CA2256522A1 Polynucleotides encoding secreted proteins |
12/11/1997 | CA2256520A1 Polynucleotides encoding secreted proteins from human dendritic cells |
12/11/1997 | CA2256484A1 Vectors comprising sar elements |
12/11/1997 | CA2254862A1 Metabotropic gaba[b] receptors, receptor-specific ligands and their uses |
12/11/1997 | CA2254819A1 Inhibition of hiv-1 replication by antisense rna expression |
12/11/1997 | CA2253262A1 Transgenic animals expressing artificial epitope-tagged proteins |
12/10/1997 | EP0811691A1 Antibody againts alpha-chain of human interleukin 5 receptor |
12/10/1997 | EP0811686A2 Human platelet-derived growth factor receptors |
12/10/1997 | EP0811685A2 Human platelet-derived growth factor receptors |
12/10/1997 | EP0811684A2 Oxytocin receptor portion or variant, and dna coding for the same |
12/10/1997 | EP0811160A1 Nf-kappa b activation regulatory protein, i-kappa b-beta |
12/10/1997 | EP0811078A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth |
12/10/1997 | EP0811076A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF |
12/10/1997 | EP0811074A1 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
12/10/1997 | EP0811072A1 Transgenic animals as model of psoriasis |
12/10/1997 | EP0811070A1 Method to obtain male-sterile plants |
12/10/1997 | EP0811067A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |